Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Eslicarbazepine Acetate on Warfarin PK/PD in Healthy Volunteers
NCT02287415Phase 1Completed
- Sponsor
- BIAL
- Start
- May 2002
- Primary completion
- Jul 2002
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of eslicarbazepine acetate in epilepsy, sponsored by BIAL. Primary endpoint: Maximum Steady-state Plasma Concentration. Started May 2002; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02287415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02287415.